Healthcare News

Ligand to Host Investor Day on December 8, 2026

BEDFORD, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue...

WATERTOWN, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader...

SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that it will report financial results and business highlights for the third...

LONDON, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, October 27, 2026...

Watsonville, CA, Oct. 22, 2026 (GLOBE NEWSWIRE) -- With the supplement market flooded by varying quality standards, experts at Nordic Naturals have revealed four essential questions every consumer...

IQity reports strong surgeon interest at its first AAO exhibition: IQ-SurgiView, handheld ECP with IQ-Flow and compact IQ-Meter OCT, launch early 2027.

New late-breaking data presented today at ASN Kidney Week 2026 QUELIMMUNE (SCD-PED) treatment group demonstrates statistically significant higher survival in the primary analysis at Day 60, Day 90,...

Walden Biosciences announced initial results from Phase 1 and Phase 2 studies of WAL0921 that demonstrated a clinically meaningful reduction in proteinuria

Data from pre-clinical renal disease models demonstrate potential of izicopan for kidney protectionStructural modeling provides new insight into izicopan’s differentiated molecular profile Jena,...